| Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease CA McLean, RA Cherny, FW Fraser, SJ Fuller, MJ Smith, K Vbeyreuther, ... Annals of neurology 46 (6), 860-866, 1999 | 2538 | 1999 |
| Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice RA Cherny, CS Atwood, ME Xilinas, DN Gray, WD Jones, CA McLean, ... Neuron 30 (3), 665-676, 2001 | 1873 | 2001 |
| Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial CW Ritchie, AI Bush, A Mackinnon, S Macfarlane, M Mastwyk, ... Archives of neurology 60 (12), 1685-1691, 2003 | 1248 | 2003 |
| Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits CC Curtain, F Ali, I Volitakis, RA Cherny, RS Norton, K Beyreuther, ... Journal of Biological Chemistry 276 (23), 20466-20473, 2001 | 847 | 2001 |
| Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ PA Adlard, RA Cherny, DI Finkelstein, E Gautier, E Robb, M Cortes, ... Neuron 59 (1), 43-55, 2008 | 798 | 2008 |
| Metalloenzyme-like activity of Alzheimer's disease β-amyloid: Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2 C Opazo, X Huang, RA Cherny, RD Moir, AE Roher, AR White, R Cappai, ... Journal of Biological Chemistry 277 (43), 40302-40308, 2002 | 788 | 2002 |
| Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease D Kaur, F Yantiri, S Rajagopalan, J Kumar, JQ Mo, R Boonplueang, ... Neuron 37 (6), 899-909, 2003 | 769 | 2003 |
| Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion RA Cherny, JT Legg, CA McLean, DP Fairlie, X Huang, CS Atwood, ... Journal of Biological Chemistry 274 (33), 23223-23228, 1999 | 672 | 1999 |
| Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export P Lei, S Ayton, DI Finkelstein, L Spoerri, GD Ciccotosto, DK Wright, ... Nature medicine 18 (2), 291-295, 2012 | 650 | 2012 |
| Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease LE Goldstein, JA Muffat, RA Cherny, RD Moir, MH Ericsson, X Huang, ... The Lancet 361 (9365), 1258-1265, 2003 | 602 | 2003 |
| Copper in the brain and Alzheimer’s disease YH Hung, AI Bush, RA Cherny JBIC Journal of Biological Inorganic Chemistry 15, 61-76, 2010 | 552 | 2010 |
| Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron CJ Maynard, R Cappai, I Volitakis, RA Cherny, AR White, K Beyreuther, ... Journal of Biological Chemistry 277 (47), 44670-44676, 2002 | 468 | 2002 |
| Mitochondrial oxidative stress causes hyperphosphorylation of tau S Melov, PA Adlard, K Morten, F Johnson, TR Golden, D Hinerfeld, ... PloS one 2 (6), e536, 2007 | 429 | 2007 |
| Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42 PJ Crouch, R Blake, JA Duce, GD Ciccotosto, QX Li, KJ Barnham, ... Journal of Neuroscience 25 (3), 672-679, 2005 | 400 | 2005 |
| Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: a target for neuroprotection in the central nervous system A Siddiq, IA Ayoub, JC Chavez, L Aminova, S Shah, JC LaManna, ... Journal of Biological Chemistry 280 (50), 41732-41743, 2005 | 370 | 2005 |
| Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity AR White, T Du, KM Laughton, I Volitakis, RA Sharples, ME Xilinas, ... Journal of Biological Chemistry 281 (26), 17670-17680, 2006 | 362 | 2006 |
| Dopamine promotes α‐synuclein aggregation into SDS‐resistant soluble oligomers via a distinct folding pathway R Cappai, SL Leck, DJ Tew, NA Williamson, DP Smith, D Galatis, ... The FASEB journal 19 (10), 1377-1379, 2005 | 334 | 2005 |
| Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106− 126 MF Jobling, X Huang, LR Stewart, KJ Barnham, C Curtain, I Volitakis, ... Biochemistry 40 (27), 8073-8084, 2001 | 331 | 2001 |
| Elevated cortical zinc in Alzheimer disease D Religa, D Strozyk, RA Cherny, I Volitakis, V Haroutunian, B Winblad, ... Neurology 67 (1), 69-75, 2006 | 327 | 2006 |
| Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation PJ Crouch, LW Hung, PA Adlard, M Cortes, V Lal, G Filiz, KA Perez, ... Proceedings of the National Academy of Sciences 106 (2), 381-386, 2009 | 318 | 2009 |
David I FinkelsteinFlorey, AustraliaEmail verificata su unimelb.edu.au